My NCBI | Sign In
RSS Settings
  • Search: Thallas-Bonke V[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

    Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, Forbes JM.

    J Am Soc Nephrol. 2009 Apr;20(4):742-52. Epub 2009 Jan 21.PMID: 19158353 [PubMed - indexed for MEDLINE]Related articles

    2.

    Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.

    Diabetes. 2008 Feb;57(2):460-9. Epub 2007 Oct 24.PMID: 17959934 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

    Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

    Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.PMID: 17420349 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

    Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM.

    Endocrinology. 2007 Feb;148(2):886-95. Epub 2006 Nov 16.PMID: 17110423 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.

    Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P.

    J Am Soc Nephrol. 2006 Sep;17(9):2484-94. Epub 2006 Aug 16.PMID: 16914537 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products.

    Zimanyi MA, Denton KM, Forbes JM, Thallas-Bonke V, Thomas MC, Poon F, Black MJ.

    Diabetologia. 2006 Apr;49(4):801-10. Epub 2006 Feb 23.PMID: 16496120 [PubMed - indexed for MEDLINE]Related articles

    7.

    Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

    Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, Bassal S, El-Osta A, Long DM, Panagiotopoulos S, Jerums G, Osicka TM, Cooper ME.

    J Am Soc Nephrol. 2005 Aug;16(8):2363-72. Epub 2005 Jun 1.PMID: 15930093 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy.

    Forbes JM, Thallas-Bonke V, Cooper ME, Thomas MC.

    Curr Pharm Des. 2004;10(27):3361-72. Review.PMID: 15544521 [PubMed - indexed for MEDLINE]Related articles

    9.

    Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM.

    Diabetes. 2004 Nov;53(11):2921-30.PMID: 15504973 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity